BridgeMD
New treatment option for Plaque Psoriasis
Official title Modifying PEST for Psoriatic Arthritis Screening
ClinicalTrials.gov ID: NCT06382051
What this study is testing
- What it's testing
- The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants with moderate-to-severe plaque PsO in Canada.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Moderate-to-severe plaque PsO patients who are candidates for bDMARDs, according to physician's clinical judgement at the time of patient enrollment.
- Adult patients at the time of informed consent signature
- Patients able to understand and willing to comply with protocol requirements, instructions, and restrictions
- Residents of Canada Key
You likely can't join if
- Patients who have previously screened positive for PsA through PEST.
- Patients who have been diagnosed with PsA.
- Patients who have been diagnosed with inflammatory arthritis unrelated to PsA (rheumatoid arthritis, reactive arthritis, enteropathic arthritis...
- Patients treated with a bDMARD for moderate-to-severe plaque PsO or any other medical condition within the last 6 months prior to patient enrollment.
The study team makes the final eligibility decision.
Where it's taking place
- Calgary, Alberta, Canada
- Edmonton, Alberta, Canada
- Kelowna, British Columbia, Canada
- Surrey, British Columbia, Canada
- Winnipeg, Manitoba, Canada
- Fredericton, New Brunswick, Canada
- Barrie, Ontario, Canada
- Greater Sudbury, Ontario, Canada
- Hamilton, Ontario, Canada
- London, Ontario, Canada
- Markham, Ontario, Canada
- Ottawa, Ontario, Canada
- Richmond Hill, Ontario, Canada
- Stoney Creek, Ontario, Canada
- Toronto, Ontario, Canada
- Waterloo, Ontario, Canada
- Montreal, Quebec, Canada
- Québec, Quebec, Canada
- Ste-Foy, Quebec, Canada
- Verdun, Quebec, Canada
+ 1 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Calgary, Alberta, Canada; Edmonton, Alberta, Canada; Kelowna, British Columbia, Canada; Surrey, British Columbia, Canada; Winnipeg, Manitoba, Canada; Fredericton, New Brunswick, Canada and 15 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.